EXIMIAS PHARMACEUTICAL CORPORATION

eximias-pharmaceutical-corporation-logo

Eximias Pharmaceutical Corporation is a healthcare and pharmaceutical company. It focuses on the acquisition, development, and commercialization of unique oncology and infectious disease products. The company has three novel, late-stage products, THYMITAQ(R) and ORATAQ(TM) for oncology, and MACROTAC(TM) for oncology and infectious disease. THYMITAQ(R), the company's flagship product, is being evaluated in a Phase III ETHECC(C) trial for the treatment of patients with unresectable liver cancer. Eximias Pharmaceutical Corporation was founded in 1997. The company was founded by YM BioSciences on April 1, 2006.

#People #Financial #More

EXIMIAS PHARMACEUTICAL CORPORATION

Industry:
Biotechnology Health Care Medical

Founded:
1997-01-01

Address:
Berwyn, Pennsylvania, United States

Country:
United States

Total Employee:
1+

Status:
Active

Total Funding:
0


Current Employees Featured

not_available_image

Alan Y. Kwan
Alan Y. Kwan Member Of The Board Of Directors @ Eximias Pharmaceutical Corporation
Member Of The Board Of Directors

Investors List

birchmere-ventures_image

Birchmere Ventures

Birchmere Ventures investment in Seed Round - Eximias Pharmaceutical Corporation

More informations about "Eximias Pharmaceutical Corporation" on Search Engine